References
- Van Weelden H, De la Faille H B, Young E, et al. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1983; 119: 11–19
- Schothorst A A, Boer J, Suurmond D, et al. Application of controlled high dose rates in UV-B phototherapy for psoriasis. Br J Dermatol 1984; 110: 81–7
- Taylor C R, Stern R S, Leyden JJ, et al. Photoaging photodamage and photoprotection. J Am Acad Dermatol 1990; 22: 1–15
- Stern R S, Laird N. The carcinogenic risk of treatments for severe psoriasis. The photochemotherapy follow-up study. Cancer 1994; 73: 2759–64
- Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The photochemotherapy follow-up study. N Engl J Med 1990; 322: 1093–7
- Slaper H, Schothorst A A, Van der Leun JC. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients. Photodermatology 1986; 3: 271–83
- Deleixhe-Mauhin F, Krezinski J M, Rorive G, et al. Quantification of skin color in patients undergoing maintenance hemodialysis. J Am Acad Dermatol 1992; 27: 950–3
- Wulf HC. A method and an apparatus for determining an individuals ability to stand exposure to ultraviolet radiation. International publication number WO 93 16635. World Intellectual Property Organization (PCT) 1993; 1–41
- Bech-Thomsen N, Angelo H R, Wulf HC. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen. Arch Dermatol 1994; 130: 464–8
- Parrish J A, Jaenicke K F, Anderson RR. Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol 1982; 36: 187–91
- Gange R W, Park Y-K, Auletta M, . Action spectra for cutaneous responses to ultraviolet radiation. The biological effects of UVA radiation., F Urbach, RW Gange, et al. Praeger Publishers, New York 1986; 57–65
- Fitzpatrick TB. Ultraviolet-induced pigmentary changes: benefits and hazards. Curr Probl Dermatol 1986; 15: 25–38
- Bech-Thomsen N, Ravnborg L, Wulf HC. A quantitative study of the melanogenic effect of multiple suberythemal doses of different ultraviolet radiation sources. Photodermatol Photoimmunol Photomed 1994; 10: 53–6
- Parrish J A, Zaynoun S, Anderson RR. Cumulative effects of repeated subthreshold doses of ultraviolet radiation. J Invest Dermatol 1981; 76: 356–8
- Bech-Thomsen N, Wulf H C, Poulsen T, et al. Photocarcinogenesis in hairless mice induced by ultraviolet A tanning devices with or without subsequent solar-simulated ultraviolet irradiation. Photodermatol Photoimmunol Photomed 1991; 8: 139–45
- McKinlay A F, Diffey BL. A reference spectrum for ultraviolet-induced erythema in human skin. Human exposure to ultraviolet radiation: risks and regulations., WF Passchier, BFM Bosnjakovic. Elsevier, Amsterdam 1987; 173–190
- Adrian R M, Parrish J A, Momtaz TK, et al. Outpatient phototherapy for psoriasis. Arch Dermatol 1981; 117: 623–6
- Green C, Ferguson J, Lakshmipathi T, et al. 311 nm UVB phototherapy-an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691–6
- Storbeck K, Hölzle E, Schürer N, et al. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol 1993; 28: 227–31
- Kerscher M, Volkenandt M, Plewig G, et al. Combination phototherapy of psoriasis with calcipotriol and narrowband UVB. Lancet (letter) 1993; 342: 923
- Carabott F M, Hawk J LM. A modified dosage schedule for increased efficiency in PUVA treatment of psoriasis. Clin Exp Dermatol 1989; 14: 337–40
- Imai S. Reactions of uninvolved psoriatic skin and normal skin to ultraviolet radiation. J Am Acad Dermatol 1994; 30: 657–60
- Ho V C, Griffiths C EM, Ellis CN, et al. Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmokinetic study. J Am Acad Dermatol 1990; 22: 94–100
- Berth-Jones J, Fletcher A, Hutchinson PE. Epidermal cytokeratin and immunocyte responses during treatment of psoriasis with calcipotriol and betamethasone valerate. Br J Dermatol 1992; 126: 356–61